147 related articles for article (PubMed ID: 24785905)
1. TIMES-SS--recent refinements resulting from an industrial skin sensitisation consortium.
Patlewicz G; Kuseva C; Mehmed A; Popova Y; Dimitrova G; Ellis G; Hunziker R; Kern P; Low L; Ringeissen S; Roberts DW; Mekenyan O
SAR QSAR Environ Res; 2014; 25(5):367-91. PubMed ID: 24785905
[TBL] [Abstract][Full Text] [Related]
2. TIMES-SS--a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivity.
Patlewicz G; Dimitrov SD; Low LK; Kern PS; Dimitrova GD; Comber MI; Aptula AO; Phillips RD; Niemelä J; Madsen C; Wedebye EB; Roberts DW; Bailey PT; Mekenyan OG
Regul Toxicol Pharmacol; 2007 Jul; 48(2):225-39. PubMed ID: 17467128
[TBL] [Abstract][Full Text] [Related]
3. TIMES-SS--a mechanistic evaluation of an external validation study using reaction chemistry principles.
Roberts DW; Patlewicz G; Dimitrov SD; Low LK; Aptula AO; Kern PS; Dimitrova GD; Comber MI; Phillips RD; Niemelä J; Madsen C; Wedebye EB; Bailey PT; Mekenyan OG
Chem Res Toxicol; 2007 Sep; 20(9):1321-30. PubMed ID: 17713962
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of selected (Q)SARs/expert systems for predicting skin sensitisation potential.
Fitzpatrick JM; Roberts DW; Patlewicz G
SAR QSAR Environ Res; 2018 Jun; 29(6):439-468. PubMed ID: 29676182
[TBL] [Abstract][Full Text] [Related]
5. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
Roberts DW; Schultz TW; Api AM
Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
[TBL] [Abstract][Full Text] [Related]
6. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
[TBL] [Abstract][Full Text] [Related]
7. Skin sensitisation, adverse outcome pathways and alternatives.
Basketter D
Altern Lab Anim; 2016 Oct; 44(5):431-436. PubMed ID: 27805825
[TBL] [Abstract][Full Text] [Related]
8. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential.
Roberts DW; Aptula AO; Patlewicz G; Pease C
J Appl Toxicol; 2008 May; 28(4):443-54. PubMed ID: 17703503
[TBL] [Abstract][Full Text] [Related]
9. A comparison of reactivity schemes for the prediction skin sensitization potential.
Patlewicz G; Roberts DW; Uriarte E
Chem Res Toxicol; 2008 Feb; 21(2):521-41. PubMed ID: 18189364
[TBL] [Abstract][Full Text] [Related]
10. The activity of methacrylate esters in skin sensitisation test methods: A review.
Kimber I
Regul Toxicol Pharmacol; 2019 Jun; 104():14-20. PubMed ID: 30826317
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential.
Patlewicz G; Aptula AO; Uriarte E; Roberts DW; Kern PS; Gerberick GF; Kimber I; Dearman RJ; Ryan CA; Basketter DA
SAR QSAR Environ Res; 2007; 18(5-6):515-41. PubMed ID: 17654336
[TBL] [Abstract][Full Text] [Related]
12. Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach.
Enoch SJ; Madden JC; Cronin MT
SAR QSAR Environ Res; 2008; 19(5-6):555-78. PubMed ID: 18853302
[TBL] [Abstract][Full Text] [Related]
13. Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
Dimitrov S; Detroyer A; Piroird C; Gomes C; Eilstein J; Pauloin T; Kuseva C; Ivanova H; Popova I; Karakolev Y; Ringeissen S; Mekenyan O
J Appl Toxicol; 2016 Dec; 36(12):1568-1578. PubMed ID: 27080242
[TBL] [Abstract][Full Text] [Related]
14. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
[TBL] [Abstract][Full Text] [Related]
15. Probabilistic hazard assessment for skin sensitization potency by dose-response modeling using feature elimination instead of quantitative structure-activity relationships.
Luechtefeld T; Maertens A; McKim JM; Hartung T; Kleensang A; Sá-Rocha V
J Appl Toxicol; 2015 Nov; 35(11):1361-1371. PubMed ID: 26046447
[TBL] [Abstract][Full Text] [Related]
16. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
[TBL] [Abstract][Full Text] [Related]
17. Classification of contact allergens according to potency: proposals.
Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
[TBL] [Abstract][Full Text] [Related]
18. Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy.
Jaworska JS; Natsch A; Ryan C; Strickland J; Ashikaga T; Miyazawa M
Arch Toxicol; 2015 Dec; 89(12):2355-83. PubMed ID: 26612363
[TBL] [Abstract][Full Text] [Related]
19. An alternative strategy to the use of guinea pigs for the identification of skin sensitization hazard.
Basketter DA; Scholes EW; Chamberlain M; Barratt MD
Food Chem Toxicol; 1995 Dec; 33(12):1051-6. PubMed ID: 8847001
[TBL] [Abstract][Full Text] [Related]
20. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
